Peer-influenced content. Sources you trust. No registration required. This is HCN.
Clinical Advances in Hematology & Oncology
A gynecologic oncologist reviews the current role of immune checkpoint inhibition across locally advanced and recurrent cervical cancer settings, including KEYNOTE-A18 survival data, key regulatory distinctions, and unanswered sequencing questions.
Medical Oncology June 2nd 2026
MDSpire News
The Aptima HPV assay uses messenger RNA detection to identify infections most likely to lead to cervical cancer.
Medical Oncology February 11th 2026
Medical News Today (MNT)
“By including FDA-approved HPV self collection tests in the guidelines, they have allowed for women to get some screening even if they do not have easy access to health care.”
Obstetrics & Gynecology January 13th 2026
“Cancer detection was nearly 9 times higher among older women: 0.92 per 1000 vs 0.10 per 1000.”
Medical Oncology July 30th 2025
MDLinx
The rise in oropharyngeal cancer rates, linked to high-risk HPV strains transmitted through oral sex, underscores the need for healthcare providers to promote safe sex practices, HPV vaccination, and early symptom recognition.
Medical Oncology August 7th 2023
Journal of Clinical Oncology
This editorial reflects on the work by Lei and colleagues in teasing out hrHPV-negative vs. positive ovarian cancers with a 15-year follow up. But what to do with the knowledge?
Medical Oncology May 11th 2022
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS